Journey Strategic Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
3,254
+1,062
| +48% | +$431K | 0.04% | 125 |
|
|
2025
Q1 | $1.09M | Buy |
2,192
+506
| +30% | +$252K | 0.04% | 124 |
|
|
2024
Q4 | $877K | Sell |
1,686
-299
| -15% | -$156K | 0.03% | 139 |
|
|
2024
Q3 | $1.23M | Buy |
1,985
+292
| +17% | +$181K | 0.05% | 108 |
|
|
2024
Q2 | $936K | Buy |
1,693
+325
| +24% | +$180K | 0.04% | 96 |
|
|
2024
Q1 | $795K | Sell |
1,368
-561
| -29% | -$326K | 0.04% | 93 |
|
|
2023
Q4 | $1.02M | Buy |
1,929
+268
| +16% | +$142K | 0.05% | 61 |
|
|
2023
Q3 | $841K | Buy |
1,661
+223
| +16% | +$113K | 0.04% | 68 |
|
|
2023
Q2 | $750K | Sell |
1,438
-675
| -32% | -$352K | 0.03% | 68 |
|
|
2023
Q1 | $1.22M | Buy |
2,113
+317
| +18% | +$183K | 0.13% | 49 |
|
|
2022
Q4 | $989K | Buy |
1,796
+372
| +26% | +$205K | 0.12% | 59 |
|
|
2022
Q3 | $722K | Buy |
1,424
+551
| +63% | +$279K | 0.1% | 51 |
|
|
2022
Q2 | $475K | Sell |
873
-314
| -26% | -$171K | 0.06% | 59 |
|
|
2022
Q1 | $701K | Buy |
1,187
+61
| +5% | +$36K | 0.08% | 33 |
|
|
2021
Q4 | $751K | Buy |
+1,126
| New | +$751K | 0.08% | 50 |
|